The COVID-19 pandemic has and continues to change attitudes towards leadership, crisis management, and collaboration. We spoke to several thought leaders who shared with us their experience of navigating operations through a changing landscape as well as their hopes for the future – conversations that you can find below. But beyond COVID-19 there are other areas of unmet need that the industry is working to address. We've highlighted two of them: the development of drugs for rare diseases and non-alcoholic steatohepatitis.
|